Request for Information: Training and Care Delivery Models for Safe Administration of Potential FDA-Approved Psychedelic Therapies in Ambulatory Clinical Settings

On April 18, 2026, President Trump issued Executive Order (EO) 14401, “Accelerating Medical Treatments for Serious Mental Illness”, acknowledging that individuals suffering from serious mental illness may not always respond to existing therapies. This request for information (RFI) solicits stakeholder feedback on training and care delivery models that could be used to ensure safe and effective delivery of potential future Food and Drug Administration (FDA)-approved psychedelic drugs, including drugs administered in ambulatory clinic settings, such as health centers and rural health clinics.